---
/**
 * Thesis Section 13: M&A Path
 * Big pharma acquisition path
 */
interface Props {
  id?: string;
}

const { id = 'ma-path' } = Astro.props;
---

<section class="slide slide-ma" id={id}>
  <div class="slide-gradient slide-gradient-shift"></div>
  <div class="slide-content">
    <h2 class="section-title reveal-item" data-reveal="fade-up" style="--delay: 0ms;">üè¢ Acquisitions by Big Pharma</h2>
    <p class="section-body reveal-item" data-reveal="fade-up" style="--delay: 100ms;">
      Large pharma companies facing patent cliffs are increasingly acquiring
      longevity-adjacent assets to sustain growth.
    </p>
    <div class="path-points">
      <div class="path-point reveal-item" data-reveal="fade-up" style="--delay: 200ms;">
        <h4>Massive Market Growth</h4>
        <p>Global anti-aging therapeutics projected to grow from $5.7B (2024) to $34.6B by 2035.</p>
      </div>
      <div class="path-point reveal-item" data-reveal="fade-up" style="--delay: 300ms;">
        <h4>M&A as Core Return Driver</h4>
        <p>Institutional investors expect continued M&A as pharma uses acquisitions to access innovative platforms.</p>
      </div>
      <div class="path-point reveal-item" data-reveal="fade-up" style="--delay: 400ms;">
        <h4>Strategic Fit</h4>
        <p>Longevity mechanisms intersect with existing pharma markets‚Äîcardiometabolic, oncology, ophthalmology.</p>
      </div>
      <div class="path-point reveal-item" data-reveal="fade-up" style="--delay: 500ms;">
        <h4>VC Capital Precursor</h4>
        <p>Longevity VC funds raised over $3B in 2023, seeding future acquisition targets.</p>
      </div>
    </div>
  </div>
</section>

<style>
  .path-points {
    display: grid;
    grid-template-columns: repeat(2, 1fr);
    gap: 1.5rem;
  }

  @media (max-width: 768px) {
    .path-points {
      grid-template-columns: 1fr;
    }
  }

  .path-point {
    padding: 1.5rem;
    border-radius: 1rem;
  }

  .path-point h4 {
    font-size: 1rem;
    font-weight: 600;
    margin-bottom: 0.5rem;
  }

  .path-point p {
    font-size: 0.875rem;
    line-height: 1.5;
  }

  :global([data-mode="dark"]) .path-point {
    background: rgba(15, 9, 35, 0.8);
    border: 1px solid rgba(108, 99, 255, 0.15);
  }

  :global([data-mode="dark"]) .path-point h4 {
    color: var(--color-alabaster);
  }

  :global([data-mode="dark"]) .path-point p {
    color: rgba(249, 250, 251, 0.6);
  }
</style>
